Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04877652 · ClinicalTrials.gov registry record
DR REGISTRY: Prospective Observational Study of ADHF Patients With Insufficient Response to Diuretics
A clinical trial, sponsored by Revamp Medical.
- Completed
- Registry status
- 6
- Enrollment target
NCT04877652: Completed study, sponsored by Revamp Medical.
NCT04877652 is a clinical trial that has completed, run by Revamp Medical. The registered enrollment target is 6 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04877652 has completed, sponsored by Revamp Medical.
- COMPLETED
- Registry status
- 6 participants
- Enrollment target
Study Summary
The study objective is to observe and measure clinical outcomes, urine output, and safety events occurring during standard medical treatment of ADHF patients deemed to have insufficient diuretic response.
Primary Outcome
SAEs (including MACE) post enrollment based on CEC adjudication.
Interventions
- OTHER Standard of care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2021-11-17 |
| Est. Completion | 2022-05-25 |
What the finished NCT04877652 record still lists
NCT04877652 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 6 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Standard of care is the first listed.
NCT04877652 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04877652 about?
NCT04877652 is a clinical study titled "DR REGISTRY: Prospective Observational Study of ADHF Patients With Insufficient Response to Diuretics". The study objective is to observe and measure clinical outcomes, urine output, and safety events occurring during standard medical treatment of ADHF patients deemed to have insufficient diuretic response.
What is the current status of trial NCT04877652?
This trial is currently completed. The enrollment target is 6 participants. The study started on 2021-11-17. Estimated completion is 2022-05-25.
What interventions are being tested in trial NCT04877652?
The interventions under investigation include: Standard of care (OTHER).
Who is sponsoring clinical trial NCT04877652?
This trial is sponsored by Revamp Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI